Conflicts of interest
CRM has received funding for investigator-driven research from Merck, GSK and Seqirus, and support for laboratory testing unrelated to this study from Pfizer. CRM has also been on advisory boards for the same companies. DCA, XC, MS, DD and JK have no competing interests to declare.